Weight-loss drug maker sues rival over which GLP-1 sheds the most pounds
www.independent.co.uk
Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds